Post-hoc Analysis of the Tofogliflozin Post-Marketing Surveillance Study (J-STEP/LT): Tofogliflozin Improves Liver Function in Type 2 Diabetes Patients Regardless of BMI.
Journal of diabetes investigation（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined